MedKoo Cat#: 565472 | Name: Tonantzitlolone

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Tonantzitlolone is a natural agonist of tprc1/4/5 channels, also acting as a dual pkcα and pkcθ activator, inducing an insulin resistant phenotype by inhibiting irs1 and the pi3k/akt pathway, activating the heat shock factor 1 (hsf1) transcription factor driving glucose dependency

Chemical Structure

Tonantzitlolone
CAS#845811-30-5

Theoretical Analysis

MedKoo Cat#: 565472

Name: Tonantzitlolone

CAS#: 845811-30-5

Chemical Formula: C26H40O7

Exact Mass: 464.2774

Molecular Weight: 464.60

Elemental Analysis: C, 67.22; H, 8.68; O, 24.11

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
TZL; Tonantzitlolone; Tonantzitlolone A;
IUPAC/Chemical Name
(1R,2S,3R,6S,10S,12R,14R,15R,Z)-1,2-dihydroxy-3,7,7,10,14-pentamethyl-11-oxo-16,17-dioxatricyclo[10.3.1.13,6]heptadec-8-en-15-yl (E)-3-methylpent-2-enoate
InChi Key
YMEAIOHYSIGDJY-VDLZEVDKSA-N
InChi Code
InChI=1S/C26H40O7/c1-8-15(2)13-20(27)31-22-17(4)14-18-21(28)16(3)9-11-24(5,6)19-10-12-25(7,33-19)23(29)26(22,30)32-18/h9,11,13,16-19,22-23,29-30H,8,10,12,14H2,1-7H3/b11-9-,15-13+/t16-,17+,18+,19-,22+,23-,25+,26-/m0/s1
SMILES Code
CC/C(C)=C/C(O[C@@H]([C@@](O1)(O)[C@@H](O)[C@@]2(C)CC[C@@](O2)([H])C(C)(C)/C=C\[C@@H]3C)[C@H](C)C[C@]1([H])C3=O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 464.60 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Rubaiy HN. Treasure troves of pharmacological tools to study transient receptor potential canonical 1/4/5 channels. Br J Pharmacol. 2019 Apr;176(7):832-846. doi: 10.1111/bph.14578. Epub 2019 Mar 6. Review. PubMed PMID: 30656647; PubMed Central PMCID: PMC6433652. 2: Rubaiy HN, Ludlow MJ, Siems K, Norman K, Foster R, Wolf D, Beutler JA, Beech DJ. Tonantzitlolone is a nanomolar potency activator of transient receptor potential canonical 1/4/5 channels. Br J Pharmacol. 2018 Aug;175(16):3361-3368. doi: 10.1111/bph.14379. Epub 2018 Jun 28. PubMed PMID: 29859013; PubMed Central PMCID: PMC6057908. 3: Busch T, Dräger G, Kunst E, Benson H, Sasse F, Siems K, Kirschning A. Synthesis and antiproliferative activity of new tonantzitlolone-derived diterpene derivatives. Org Biomol Chem. 2016 Oct 14;14(38):9040-5. doi: 10.1039/c6ob01697a. Epub 2016 Sep 7. PubMed PMID: 27604289. 4: Pfeffer TJ, Sasse F, Schmidt CF, Lakämper S, Kirschning A, Scholz T. The natural diterpene tonantzitlolone A and its synthetic enantiomer inhibit cell proliferation and kinesin-5 function. Eur J Med Chem. 2016 Apr 13;112:164-170. doi: 10.1016/j.ejmech.2016.02.022. Epub 2016 Feb 8. PubMed PMID: 26896705. 5: Sourbier C, Scroggins BT, Mannes PZ, Liao PJ, Siems K, Wolf D, Beutler JA, Linehan WM, Neckers L. Tonantzitlolone cytotoxicity toward renal cancer cells is PKCθ- and HSF1-dependent. Oncotarget. 2015 Oct 6;6(30):29963-74. doi: 10.18632/oncotarget.4676. PubMed PMID: 26298773; PubMed Central PMCID: PMC4745775. 6: Olivon F, Palenzuela H, Girard-Valenciennes E, Neyts J, Pannecouque C, Roussi F, Grondin I, Leyssen P, Litaudon M. Antiviral Activity of Flexibilane and Tigliane Diterpenoids from Stillingia lineata. J Nat Prod. 2015 May 22;78(5):1119-28. doi: 10.1021/acs.jnatprod.5b00116. Epub 2015 May 6. PubMed PMID: 25946116. 7: Busch T, Kirschning A. Recent advances in the total synthesis of pharmaceutically relevant diterpenes. Nat Prod Rep. 2008 Apr;25(2):318-41. doi: 10.1039/b705652b. Epub 2008 Feb 11. Review. PubMed PMID: 18389140. 8: Jasper C, Adibekian A, Busch T, Quitschalle M, Wittenberg R, Kirschning A. Total synthesis of cyclic diterpene tonantzitlolone based on a highly stereoselective substrate-controlled aldol reaction and ring-closing metathesis. Chemistry. 2006 Nov 24;12(34):8719-34. PubMed PMID: 16955524. 9: Jasper C, Wittenberg R, Quitschalle M, Jakupovic J, Kirschning A. Total synthesis and elucidation of the absolute configuration of the diterpene tonantzitlolone. Org Lett. 2005 Feb 3;7(3):479-82. Erratum in: Org Lett. 2005 Apr 28;7(9):1885. PubMed PMID: 15673269.